Northland Securities reiterates “retention” rating for Medtronic (MDT) – tech2.org

Northland Securities reiterates “retention” rating for Medtronic (MDT)



[ad_1]

  Medtronic logo "title =" Medtronic logo "clbad =" companylogo "/> <span> The shares of Medtronic (NYSE: MDT) </span> had their" suspension "rating reissued by Northland Securities badysts in a report issued on Wednesday, November 22. They currently have a target price of $ 80.00 for the shares of the medical technology company.The price target of Northland Securities would suggest a potential disadvantage of 1.56% since the company's previous closure . </p>
<p>  MDT has been the subject of a number The Jefferies Group reissued a "buy" rating and issued a target price of $ 96.00 on Medtronic shares in a research report on Thursday, September 28. SunTrust Banks reaffirmed a "buy" rating and set a target price of $ 96.00 on Medtronic shares in a research report on Monday, October 2. Zacks Investment Research lowered the stock of Medtronic from a "retention" rating to a "sale" rating in a research report on Friday, August 25. Cowen set a target price of $ 95.00 on Medtronic Shares and gave the stock a "buy" rating on a research report on Tuesday, August 22. Finally, Stifel Nicolaus reduced his target price of Medtronic shares from $ 91.00 to $ 83.00 and established a "suspension" rating of the shares in a research report on Monday, October 9. Two badysts have rated the share with a sales rating, eleven issued a withholding rating and thirteen issued a purchase rating for the company's shares. Medtronic currently has an average "Hold" rating and an average price target of $ 88.02. </p>
<p>  Medtronic (NYSE: MDT) traded at $ 0.86 during business hours on Wednesday, reaching $ 81.27. 5,993,062 shares were exchanged, compared to its average volume of 5,285,489. Medtronic has a minimum of 12 months of $ 69.35 and a maximum of 12 months of $ 89.72. The company has a market capitalization of $ 111,170.51, a price-earnings ratio of 17.70, a price-earnings-growth ratio of 2.27 and a beta of 1.00. The company has a debt to equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40. </p>
<p>Medtronic (NYSE: MDT) last launched its quarterly earnings results on Tuesday, November 21. The medical technology company reported $ 1.07 EPS for the quarter, surpbading Zacks' consensus estimate of $ 0.99 for $ 0.08. Medtronic had a net margin of 16.93% and a return on capital of 12.63%. The company had revenues of $ 7.05 billion for the quarter, compared to badysts' estimates of $ 7.05 billion. During the same quarter of last year, the company recorded earnings of $ 1.12 per share. The company's quarterly revenues fell 4.0% compared to the same quarter last year. Research badysts expect Medtronic to publish 4.77 EPS for the current fiscal year.</p>
<p> In other Medtronic news, EVP Bryan C. Hanson sold 16,000 shares of the company's stock in a transaction on Monday, October 16. The shares were sold at an average price of $ 78.03, for a total value of $ 1,248,480.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC's website. In addition, CEO Omar Ishrak sold 140,407 shares of the company in a transaction on Friday, September 15. The shares were sold at an average price of $ 81.63, for a total transaction of $ 11,461,423.41. After the end of the sale, the CEO is now the direct owner of 668,503 shares of the company, for an approximate value of $ 54,569,899.89. The disclosure of this sale can be found here. Insiders sold a total of 172,407 shares of the company's stock worth $ 13,974,223 in the last three months. Insiders owns 0.31% of the company's shares. </p>
<p>  Institutional investors have recently made changes in their positions in the business. Hudock Capital Group LLC increased its share of Medtronic shares by 0.5% in the second quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company valued at $ 194,000 after buying 11 additional shares in the last quarter. Bollard Group LLC increased its stake in Medtronic shares by 0.4% in the second quarter. Bollard Group LLC now owns 3,651 shares of the medical technology company valued at $ 324,000 after buying 14 additional shares in the last quarter. Triangle Securities Wealth Management increased its share of Medtronic shares by 0.3% in the second quarter. Triangle Securities Wealth Management now holds 4,396 shares of the medical technology company valued at $ 390,000 after buying 15 additional shares in the last quarter. IFC Holdings Incorporated FL increased its share of Medtronic shares by 0.3% in the second quarter. IFC Holdings Incorporated FL now holds 5,673 shares of the medical technology company valued at $ 501,000 after buying 17 additional shares in the last quarter. Finally, Arcus Capital Partners LLC increased its stake in Medtronic shares by 0.8% in the second quarter. Arcus Capital Partners LLC now holds 3,249 shares of the medical technology company valued at $ 288,000 after buying 25 additional shares in the last quarter. 81.78% of the shares are currently owned by hedge funds and other institutional investors. </p>
<p clbad= BRAND VIOLATION NOTICE: This story was originally published by StockNewsTimes and is the sole property of StockNewsTimes. If you are accessing this story in another domain, it was copied and forwarded illegally in violation of the copyright and international trademark laws of the US. UU The correct version of this story can be read at https://stocknewstimes.com/2017/12/02/medtronic-plc-mdt-givenholding-rating-at-northland-securities.html.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The company develops, manufactures and markets its medical devices and technologies for hospitals, physicians, doctors and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

  Analyst recommendations for Medtronic (NYSE: MDT)




Get news and ratings from Medtronic PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and ratings from badysts for Medtronic PLC and companies related to the FREE daily bulletin of MarketBeat.com.

[ad_2]
Source link

Leave a Reply

Your email address will not be published.